# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-009350
Filing Date
2025-03-26
Accepted
2025-03-26 16:05:40
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dyai20241231_10k.htm iXBRL | 10-K | 1635416
2 | EXHIBIT 10.2.1 | ex_727226.htm | EX-10.21 | 59891
3 | EXHIBIT 10.2.2 | ex_727227.htm | EX-10.22 | 56117
4 | EXHIBIT 19.1 | ex_794841.htm | EX-19.1 | 92211
5 | EXHIBIT 21.1 | ex_727228.htm | EX-21.1 | 1014
6 | EXHIBIT 23.1 | ex_727229.htm | EX-23.1 | 3190
7 | EXHIBIT 31.1 | ex_727231.htm | EX-31.1 | 13641
8 | EXHIBIT 31.2 | ex_727232.htm | EX-31.2 | 13758
9 | EXHIBIT 32.1 | ex_727233.htm | EX-32.1 | 4899
10 | EXHIBIT 32.2 | ex_727234.htm | EX-32.2 | 4787
16 |  | a01.jpg | GRAPHIC | 1667
17 |  | d01.jpg | GRAPHIC | 3471
18 |  | orgchart.jpg | GRAPHIC | 74558
| Complete submission text file | 0001437749-25-009350.txt |  | 8430414

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | dyai-20241231.xsd | EX-101.SCH | 61371
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dyai-20241231_cal.xml | EX-101.CAL | 60916
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dyai-20241231_def.xml | EX-101.DEF | 477335
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dyai-20241231_lab.xml | EX-101.LAB | 415429
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dyai-20241231_pre.xml | EX-101.PRE | 507544
82 | EXTRACTED XBRL INSTANCE DOCUMENT | dyai20241231_10k_htm.xml | XML | 1239588

Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32513 | Film No.: 25773171
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)